Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stryker Corporation (SYK)
NYSE:SYK
Holding SYK?
Track your performance easily
Earnings Data
Report Date
Jan 28, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
3.87Last Year’s EPS
3.46Same Quarter Last Year
Strong Buy
Based on 22 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 25, 2018
|% Change Since: 7.05%
|Next Earnings Date:Jul 24, 2018
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial performance, with significant organic sales growth, successful acquisition strategy, and robust EPS growth. Positive pricing impact and commitment to margin expansion further strengthened the outlook. However, challenges in the ischemic business, a slight decline in bone cement sales, and foreign currency headwinds were noted. Overall, the positive aspects significantly outweighed the challenges.Company Guidance
During the Stryker earnings call for Q3 2024, the company provided optimistic guidance for the remainder of the year, projecting full-year organic sales growth in the range of 9.5% to 10% and adjusted EPS between $12 and $12.10. This forecast reflects a narrowing to the high end of previously provided guidance ranges, driven by strong organic sales growth of 11.5% in the third quarter. All major business segments, including MedSurg, Neurotechnology, Orthopaedics, and Spine, exhibited robust performance, with double-digit growth across several divisions. International markets also contributed significantly, with organic growth of 11.7%. Stryker highlighted its strategic acquisitions, such as care.ai and NICO Corporation, which are expected to bolster its healthcare offerings. Additionally, the company remains committed to achieving 200 basis points of margin expansion by the end of 2025, including 100 basis points targeted for the current year.Significant Organic Sales Growth
Stryker reported a robust organic sales growth of 11.5% for Q3 2024, with strong performance across MedSurg, Neurotechnology, Orthopaedics, and Spine.
Successful Acquisitions Strategy
The company completed several acquisitions, including care.ai, NICO Corporation, and Vertos Medical, enhancing their healthcare IT and minimally invasive surgery offerings.
Strong EPS Growth
Adjusted EPS for Q3 2024 was $2.87, marking 16.7% growth compared to the same quarter last year.
Continued Mako Installations Momentum
Record Q3 installations of Mako both globally and in the U.S., with strong utilization rates driving growth in hips and knees.
Positive Pricing Impact
The company experienced a 1.2% favorable impact from pricing initiatives, contributing to the positive financial performance.
Commitment to Margin Expansion
Stryker reiterated its commitment to a 200 basis points margin expansion by the end of 2025, with 100 basis points expected this year.
Sustainable Growth in Medical Division
The Medical division posted 18.5% U.S. organic sales growth, driven by strong performances across various product lines.
---
SYK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SYK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Oct 29, 2024 | $358.18 | $362.59 | +1.23% |
| Jul 30, 2024 | $328.72 | $325.96 | -0.84% |
| Apr 30, 2024 | $334.19 | $325.86 | -2.49% |
| Jan 30, 2024 | $313.74 | $332.41 | +5.95% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Stryker Corporation (SYK) report earnings?
Stryker Corporation (SYK) is schdueled to report earning on Jan 28, 2025, TBA Not Confirmed.
What is Stryker Corporation (SYK) earnings time?
Stryker Corporation (SYK) earnings time is at Jan 28, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SYK EPS forecast?
SYK EPS forecast for the fiscal quarter 2024 (Q4) is 3.87.
---